• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI SPRINT QUATTRO SECURE MRI SURESCAN; DRUG-ELUTING PERMANENT DEFIBRILLATOR ELECTRODES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI SPRINT QUATTRO SECURE MRI SURESCAN; DRUG-ELUTING PERMANENT DEFIBRILLATOR ELECTRODES Back to Search Results
Model Number 6947M72
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 12/19/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Concomitant medical products: dtma1d4 crt-d; implanted: (b)(6) 2019.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) system was removed due to infection.No further patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was further reported that during the explant procedure, a large foul-smelling clot was found in the device pocket.The clot was removed from the device pocket.
 
Additional Manufacturer Narrative
Product event summary: the full lead was returned in segments and analyzed.Analysis indicated the proximal conductor of the lead de veloped a fracture at the first rib/clavicle location while in vivo.The exposed superior vena cava defibrillation coil was fractured.The right ventricular defibrillation coil was fractured at the 1st rib/clavicle location.The inner insulation of the lead develo ped a breach at the first rib/clavicle location while in vivo.The outer insulation of the lead developed a breach at the first rib/clavicle location while in vivo.The outer insulation of the lead was breached due to bi/multi-lumen tubing voids while in vivo.The overlay tubing was breached at the 1st rib/clavicle location.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPRINT QUATTRO SECURE MRI SURESCAN
Common Device Name
DRUG-ELUTING PERMANENT DEFIBRILLATOR ELECTRODES
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
MDR Report Key9589638
Report Number2649622-2020-01146
Device Sequence Number16266299
Product Code NVY
UDI-Device Identifier00643169082281
UDI-Public00643169082281
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P920015
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date06/25/2014
Device Model Number6947M72
Device Catalogue Number6947M72
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/21/2020
Initial Date Received by Manufacturer 12/19/2019
Supplement Date Received by Manufacturer01/21/2020
01/21/2020
Initial Report FDA Received Date01/14/2020
Supplement Report FDA Received Date01/22/2020
01/28/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
429688 LEAD, 5076-52 LEAD
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age62 YR
-
-